Comments on: Icahn Offered $23 Billion for Biogen Idec—Elan Won’t Block Sale http://www.xconomy.com/boston/2007/10/15/ichan-offered-23-billion-for-biogen-idec-elan-wont-block-sale/ Business + Technology in the Exponential Economy Sun, 22 Nov 2009 18:21:13 -0600 http://wordpress.org/?v=2.8.6 hourly 1 By: Robert Buderi http://www.xconomy.com/boston/2007/10/15/ichan-offered-23-billion-for-biogen-idec-elan-wont-block-sale/comment-page-1/#comment-1890 Robert Buderi Mon, 15 Oct 2007 15:39:33 +0000 http://www.xconomy.com/2007/10/15/ichan-offered-23-billion-for-biogen-idec-elan-wont-block-sale/#comment-1890 Hi Jim--Thanks for the note. As we reported briefly in <a href="http://www.xconomy.com/2007/08/27/carl-icahn-biogen-marriage-broker/2/" rel="nofollow">this article about Icahn</a>, Pfizer has received attention as the most likely Big Pharma suitor, but we have nothing new on this. My guess is that given the problems with Pfizer's pipeline, they would have to give this a serious look. Hi Jim–Thanks for the note. As we reported briefly in this article about Icahn, Pfizer has received attention as the most likely Big Pharma suitor, but we have nothing new on this. My guess is that given the problems with Pfizer’s pipeline, they would have to give this a serious look.

]]> By: Jim http://www.xconomy.com/boston/2007/10/15/ichan-offered-23-billion-for-biogen-idec-elan-wont-block-sale/comment-page-1/#comment-1889 Jim Mon, 15 Oct 2007 15:20:01 +0000 http://www.xconomy.com/2007/10/15/ichan-offered-23-billion-for-biogen-idec-elan-wont-block-sale/#comment-1889 Pfizer seems like it could be a worthy opponent of Icahn for Biogen based on some of these connections from NewsVisual: http://www.newsvisual.com/newsvisual/2007/10/biogen-and-pfiz.html Thoughts as to whether Pfizer actually stands a chance in becoming Icahn's 'poison pill'? Pfizer seems like it could be a worthy opponent of Icahn for Biogen based on some of these connections from NewsVisual: http://www.newsvisual.com/newsvisual/2007/10/biogen-and-pfiz.html

Thoughts as to whether Pfizer actually stands a chance in becoming Icahn’s ‘poison pill’?

]]>